Identify diagnostics and novel compounds for treatment of patients with ME/CFS.
Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is a complex multisystemic disorder that affects, among other things, the immune, nervous and endocrine systems, as well as energy metabolism. A characteristic feature of the condition is so-called Post-Exertional Malaise (PEM): a marked, often delayed worsening of symptoms or the onset of new symptoms following physical or mental exertion. Diagnosis is currently based exclusively on clinical criteria.
Funding agency: European Union (Horizon Europe)
Status: Ongoing
Timeline: 2026 – 2030